News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Melodiol Global Health.
RELATED STOCKHEAD STORIES
Health & Biotech
Melodiol’s FY23 revenue exceeds $20m as acquisition strategy proves successful
Health & Biotech
Melodiol enjoys milestone 2023 as subsidiaries bank profits
News
In Case You Missed It: Firebrick back after review points to ‘inaccuracies in trial efficacy data’
Health & Biotech
Melodiol subsidiary HHI Australia delivers $1 million revenue in October
News
In Case You Missed It: Record monthly Canadian cannabis revenue takes top spot
News
10 at 11ish: First Au gets nod for bulk sampling at Victorian gold project
Health & Biotech
‘Current inventory moving very quickly’: Melodiol’s Canadian subsidiary continues to deliver record revenue
News
Quarterly Wrap: Pot stocks shine with record revenues for Melodiol, 75pc increase in revenue for Bioxyne
News
In Case You Missed It: Quarterlies, a lithium takeover and a 1km long pegmatite body
News
Closing Bell: ASX unconvincing ahead of big CPI read and maiden address by new RBA boss
News
In Case You Missed It: Rare earths projects lead the pack
Health & Biotech
Melodiol’s Canadian subsidiary Mernova on track for highest ever monthly revenue in October
News
In Case You Missed It: Lithium takeover, a new lithium discovery and a gold asset sale
Health & Biotech
Melodiol marks another record revenue quarter with $7.5m of unaudited sales, up 265% on the PCP
News
In Case You Missed It: M&A, asset sales and biotech profits lead the way
Health & Biotech
Melodiol jumps 20pc as subsidiary Health House International’s Aussie operations deliver quarterly profit
News
